Recombinant Mycobacterium tuberculosis 11kDa allergen(Beijing Xiangrui Biological)
重组结核杆菌11kDa变态反应原（北京祥瑞）
Report date: 2022/11/27 14:23:29
Base Information
Drug NameRecombinant Mycobacterium tuberculosis 11kDa allergen(Beijing Xiangrui Biological)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBeijing Xiangrui Biological Products Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesBeijing Xiangrui Biological Products Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A